Amuvatinib (MP470) is an orally bioavailable multi-targeted tyrosine kinase inhibitor with potent activity against mutant c-Kit, PDGFRalpha, Flt3, c-Met and c-Ret. Amuvatinib (MP470) is also a DNA repair suppressor through suppression of DNA repair protein RAD51, thereby disrupting DNA damage repair[1][2][3]. Antineoplastic activity[4].
Molekulargewicht:
447.51
Reinheit:
99.40
CAS Nummer:
[850879-09-3]
Formel:
C23H21N5O3S
Target-Kategorie:
Apoptosis,c-Kit,c-Met/HGFR,FLT3,PDGFR,RAD51,RET
Anwendungsbeschreibung:
MCE Product type: Reference compound1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten